Albumin, Chromated Cr 51 Serum

CHEMBL1201450 Phase 4 Aprovado Protein
Half-Life
Bioavailability
Protein Binding
Molecular Weight
g/mol
LogP
Phase
4

A radioactively labeled albumin preparation using chromium-51 that is used as a diagnostic tracer to measure blood volume and assess protein-losing conditions in the gastrointestinal tract. The radiolabeled protein follows the same distribution as natural albumin, allowing clinicians to detect and quantify abnormal protein loss.

Mecanismo de Ação

Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mecanismo

Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.

HBD / HBA

- / -

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Perguntas frequentes

A radioactively labeled albumin preparation using chromium-51 that is used as a diagnostic tracer to measure blood volume and assess protein-losing conditions in the gastrointestinal tract. The radiolabeled protein follows the same distribution as natural albumin, allowing clinicians to detect and quantify abnormal protein loss.

Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.

Yes, Albumin, Chromated Cr 51 Serum is an approved drug. It has reached clinical phase 4. It is classified as a Protein.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201450. Open-access bioactivity database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.

Aviso Médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.